NSE is currently the most reliable tumour marker in the diagnosis, prognosis, and follow-up of small cell lung cancer (SCLC), even though increased levels of NSE have also been reported in non-SCLC (NSCLC). This evidence concerns the gene ENO2 and non-small cell lung carcinoma.